All Blogs

Nov 24, 2020

Novartis bags Mesoblast's cell therapy, Remestemcel-L for COVID-19 ARDS The COVID-19 pandemic has put tremendous pressure on scientists to develop a safe and effective vaccine as early as possible. According to the WHO, there are currently more than 100 COVID-19 vaccine candidates under development, with several...

Oct 04, 2024

The past decade experienced a lot of shuffling in the Rheumatoid arthritis market. The journey started with the approvals of disease-modifying anti-rheumatic drugs (DMARDs). Several conventional DMARDs constituting methotrexate, leflunomide, hydroxychloroquine, and sulfasalazine, biologics with initial entrants bei...

Nov 19, 2020

Pfizer succeeds COVID-19 vaccine safety milestone Pfizer prepares to file its COVID-19 vaccine for emergency use authorization (EUA) after succeeding a key safety breakthrough. Pfizer now has the median two-month follow-up data needed for securing EUA from the FDA, moving a step closer for bringing its vaccine t...

Nov 20, 2020

Summary BTC (including cholangiocarcinoma and gallbladder cancer) is a challenging malignancy with rising global incidence, especially in Asia and Latin America, driven by risk factors like chronic inflammation and liver flukes; ~65,000 incident cases in 7MM in 2024, projected to grow by 2034, with highest case...

Nov 18, 2020

Lung cancer possesses a significant global health burden and is one of the most common cancers. Worldwide, every year around 2 million new cases, and approximately 1.76 million deaths occur due to Lung cancer. To raise awareness about risk factors, signs and symptoms, and the importance of early detection of lung c...

Nov 17, 2020

Albireo Pharma Hopeful to Commercialize its PFIC Treatment by the End of the Year Albireo Pharma, spun out of AstraZeneca, has long been working on developing potential and efficient treatment drugs for the patients suffering from progressive familial intrahepatic cholestasis (PFIC), a rare disorder that leads t...

Nov 12, 2020

FDA authorizes first diagnostic test for COVID-19 antibodies that obstruct the virus from entering cells The FDA has authorized the first COVID-19 diagnostic test, which identifies whether a person has the specific antibodies known to hinder the coronavirus from entering and infecting human cells. These neutr...

Nov 16, 2020

Potential and growth of the current market The major drawback of the current antiepileptic drugs (AEDs) is their modest efficacy even at best; therefore, many patients require as many as four concurrent AEDs and contend with their host of side effects. The epilepsy market has witnessed several approvals in the l...

Nov 11, 2020

Over the years, technology has significantly transformed the whole experience of how we interact and receive services for our daily needs. Be it travelling, shopping, groceries, dining, banking, or any other day to day activity almost every sector has got revolutionised according to our requirement. Not only has th...

Oct 02, 2024

Beyond the shadow of a doubt, the Rheumatoid arthritis treatment market has witnessed strides of improvement during the last few years. There was a time when treatment for rheumatoid arthritis was confined to Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids, which could only address pain and swelling. Ho...